142 related articles for article (PubMed ID: 15809548)
1. Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD.
Mahler DA; Fierro-Carrion G; Mejia-Alfaro R; Ward J; Baird JC
Med Sci Sports Exerc; 2005 Apr; 37(4):529-35. PubMed ID: 15809548
[TBL] [Abstract][Full Text] [Related]
2. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
[TBL] [Abstract][Full Text] [Related]
3. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
O'Donnell DE; Lam M; Webb KA
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
[TBL] [Abstract][Full Text] [Related]
4. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD.
Elbehairy AF; Webb KA; Laveneziana P; Domnik NJ; Neder JA; O'Donnell DE;
Respir Physiol Neurobiol; 2018 Jun; 252-253():64-71. PubMed ID: 29578103
[TBL] [Abstract][Full Text] [Related]
5. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.
Guenette JA; Webb KA; O'Donnell DE
Respir Med; 2013 May; 107(5):708-16. PubMed ID: 23421968
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
7. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
8. Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exercise.
Calligaro GL; Raine RI; Bateman ME; Bateman ED; Cooper CB
COPD; 2014 Feb; 11(1):105-12. PubMed ID: 24152211
[TBL] [Abstract][Full Text] [Related]
9. Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocol.
Sava F; Perrault H; Brouillard C; Darauay C; Hamilton A; Bourbeau J; Maltais F
COPD; 2012 Aug; 9(4):395-400. PubMed ID: 22509905
[TBL] [Abstract][Full Text] [Related]
10. A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM.
Baldi BG; de Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
Respir Med; 2013 Nov; 107(11):1773-80. PubMed ID: 24064347
[TBL] [Abstract][Full Text] [Related]
11. Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD.
Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
Respir Physiol Neurobiol; 2010 Aug; 173(1):58-63. PubMed ID: 20601207
[TBL] [Abstract][Full Text] [Related]
12. Advantages of endurance treadmill walking compared with cycling to assess bronchodilator therapy.
Zhang X; Waterman LA; Ward J; Baird JC; Mahler DA
Chest; 2010 Jun; 137(6):1354-61. PubMed ID: 20040610
[TBL] [Abstract][Full Text] [Related]
13. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
O'Donnell DE; Hamilton AL; Webb KA
J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD.
Berton DC; Barbosa PB; Takara LS; Chiappa GR; Siqueira AC; Bravo DM; Ferreira LF; Neder JA
Thorax; 2010 Jul; 65(7):588-93. PubMed ID: 20627914
[TBL] [Abstract][Full Text] [Related]
15. Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.
Abdallah SJ; Smith BM; Ware MA; Moore M; Li PZ; Bourbeau J; Jensen D
Ann Am Thorac Soc; 2018 Oct; 15(10):1146-1158. PubMed ID: 30049223
[TBL] [Abstract][Full Text] [Related]
16. [Lung function and exercise tolerance after treatment with salmeterol or ipratropium bromide in chronic obstructive pulmonary disease].
Grzanka A; Pitsch T; Krzywiecki A; Rogala B
Pol Merkur Lekarski; 2004 Sep; 17(99):208-11. PubMed ID: 15628041
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.
Oga T; Nishimura K; Tsukino M; Sato S; Hajiro T; Mishima M
Chest; 2003 Jun; 123(6):1810-6. PubMed ID: 12796154
[TBL] [Abstract][Full Text] [Related]
18. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
[TBL] [Abstract][Full Text] [Related]
20. Dyspnea ratings for prescription of cross-modal exercise in patients with COPD.
Horowitz MB; Mahler DA
Chest; 1998 Jan; 113(1):60-4. PubMed ID: 9440569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
